Can I read Done 2020-JMedChem-Development of Bis-Cyclic Imidazolidine-4-One Derivatives As Potent Antibacterial Agents on EtoBox?
Done 2020-JMedChem-Development of Bis-Cyclic Imidazolidine-4-One Derivatives As Potent Antibacterial Agents by Jitendra Singh Hanspal is a document available to read on EtoBox.
What is Done 2020-JMedChem-Development of Bis-Cyclic Imidazolidine-4-One Derivatives As Potent Antibacterial Agents about?
The article discusses the development of bis-cyclic imidazolidine-4-one derivatives as new antibacterial agents to combat antibiotic resistance. These compounds exhibit potent antibacterial activity against various strains, including multidrug-resistant bacteria, by mimicking the properties of host-defense peptides. The study highlights the potential of these small molecules as a new generation of therapeutics due to their low production costs and effectiveness in eradicating bacterial pathogens.
- Author
- Jitendra Singh Hanspal
- Language
- EN